Pune, July 9, 2009: Bilcare Ltd., service provider to the pharmaceutical companies spanning across their value chain from drug discovery to market has strengthened its Board of Directors with effect from July 9, 2009.

Speaking on the occasion, Mr. Mohan Bhandari, Chairman & Managing Director, Bilcare Ltd., said, “ I am honoured to have Dr. Arthur Carty and Dr. Bhojraj Suresh join the Bilcare Board. With their rich experience in the industry, they will be adding immense value to the Company and its business; while our outgoing respected Board member, Shri Rakesh Jhunjhunwala, continues to be our guide and valued long term investor”.

Dr. Arthur J Carty with over 40 years of experience is currently the Executive Director, Institute for Nanotechnology and Research Professor in the department of Chemistry at the University of Waterloo. Dr. Carty served as Canada‘s first National Science Advisor to the Prime Minister and to the Government of Canada from 2004 to 2008 and as the President of the National Research Council of Canada, from 1994 to 2004. Dr. Carty has been accorded thirteen honorary degrees and is the recipient of Canada‘s highest civilian award - Officer of the Order of Canada (OC) and has also been honored by France as Officer de l‘Ordre national du Mérite. Dr. Carty has over 300 publications in peer reviewed journals and five patents to his credit.

Professor Dr. Bhojraj Suresh with over 27 years of experience is the Vice-Chancellor, JSS University and the President of Pharmacy Council of India. Dr. Suresh was conferred the Doctor of Science for his contribution in the field of pharmaceutical sciences in 2007. Dr. Suresh is the First Indian academician to be awarded the prestigious FAPA Ishidate Award and also the First Indian to be elected as the President of Asian Association of Schools of Pharmacy. Dr. Suresh who is also the current President of the Indian Pharmaceutical Association, was conferred with the “2009 Outstanding Contributor Award” by the Chemtech Foundation. Dr. Suresh has 218 National and 75 International Scientific Publications.
About Bilcare

Headquartered in India, Bilcare is an integrated service provider to the global pharmaceutical sector across their value chain through its key business activities namely: Pharma Packaging Innovation, Global Clinical Services, and Non-Clonable Technologies. These business activities encompass research, development, manufacturing and supply of products, processes, and services to the Pharma and Healthcare domain. Technologies business focuses on unique range of applications viz. security & product authentication, Track & Trace e-pedigree, medication compliance & Personalized Healthcare Management System. Bilcare operates state-of-the-art Manufacturing and Research facilities in India, Singapore, USA & UK and has regional offices in Brazil, Germany, China & Australia , while partnering with the global pharmaceutical sector by providing value solutions to address their key concerns i.e. counterfeit, compliance, cost communication and convenience.